University of Minnesota. Driven to Discover.
Vaccine development hinges on "unprecedented" and transparent efforts, top US experts say.
The shorter, simpler regimen with the new drug is poised to improve treatment against a difficult disease and to lower costs.
Panel finds overall response was thorough, but notes policy gaps and some missteps after the samples were found.
The budget supports earlier commitment to Gavi vaccine initiatives but dials back funds for other global health efforts.
A new FDA approval pathway is for antimicrobials that treat serious infections.
High-containment labs across the US government, including the CDC, have safety gaps, the GAO says.
The first batch of an experimental Ebola vaccine landed today in an outbreak country, with officials projecting a trial launch in Liberia within weeks.
The multipronged attack includes an executive order, a national strategy, and a detailed PCAST report.
In addition to recent problems with anthrax and smallpox, high-path avian flu has now entered the mix.
Testing to determine whether the vials contain live virus will take 2 weeks, the CDC said.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2020 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.